To elucidate physiological mechanisms underlying pathological anxiety, valid animal models are essential (Cryan and Holmes 2005). Previous studies confirmed that the high anxiety-related behavior/low anxiety-related behavior (HAB/ LAB) mouse model for trait anxiety mimics many clinically relevant features typical of psychiatric patients (Krömer et al. 2005;Landgraf et al. 2007). In this model, behavioral phenotyping on the elevated-plus-maze (EPM) test was used as selection criterion for bidirectional intra-strain (CD1) breeding. Consequently, inbreeding for more than 30 generations created hyper-anxious (HAB) and hypo-anxious (LAB) mice. These animals provide robust phenotypes for extremes in anxiety-related behavior, and show high comorbidity with depression-like behavior. Inbreeding with focus on a particular trait included a strong accumulation of specific genetic material. Therefore, HAB/LAB animals serve as a potent model to analyze candidates underlying trait anxiety. One of the first protein markers shown to be differentially regulated in extremes of trait anxiety was glyoxalase1 (GLO1; lactoylglutathione lyase, EC 4.4.1.5).Mouse GLO1 is an enzyme of 21kDa, containing 184 amino acids that is found as a dimer in the cytosol of cells. Its physiological function is the catalytic conversion of Abbreviations used: AGE, advanced glycation end; ARMS, amplification refractory mutation system; CNV, copy number variant; enpp5, ectonucleotide pyrophosphatase/phosphodiesterase 5; EPM, elevatedplus-maze; GC-MS, gas chromatography-mass spectrometry; GLO1, glyoxalase1; HAB, high anxiety-related behavior; i.c.v., intracerebroventricular; LAB, low anxiety-related behavior; LTP, long-term potentiation; MG, methylglyoxal; NAB, normal anxiety-related behavior; TST, tail suspension test; WB, western blotting.
AbstractMethylglyoxal (MG) is a highly reactive metabolite that forms adducts with basic amino acid side chains in proteins. MG is degraded by glyoxalase1 (GLO1), an enzyme shown to be differentially expressed in several mouse models of anxietyrelated behavior. As yet, molecular mechanisms by which altered GLO1 expression influences emotionality have not been elucidated. Here we report that both MG concentration and protein modification are altered in brain tissue of a mouse model for trait anxiety, with elevated levels in low anxiety-related behavior relative to high anxiety-related behavior animals. Accordingly, repeated intracerebroventricular injections of MG mediated anxiolysis in inbred high anxiety-related behavior and outbred CD1 mice. We found that anxiolytic-like properties of MG were independent of GLO1 expression. In contrast, antidepressant-like properties of intracerebroventricular MG were suppressed in CD1 mice carrying extra copies of the GLO1 gene. Moreover, MG treatment increased expression of GLO1 only in CD1 mice that did not have extra copies of GLO1. Taken together, these results suggest that the MG levels in brain are negatively correlated with anxiety. Thereby, we identified a novel molecular mec...